Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06244147 · ClinicalTrials.gov registry record
Long Term Safety and Efficacy of KSM-66 Ashwagandha in Adults
A clinical trial, sponsored by SF Research Institute.
- Completed
- Registry status
- 200
- Enrollment target
NCT06244147 is a clinical trial that has completed, run by SF Research Institute. The registered enrollment target is 200 participants.
The verdict
NCT06244147 has completed, sponsored by SF Research Institute.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The primary objective is to evaluate the clinical safety of KSM-66 Ashwagandha (Withania Somnifera) on long-term administration over 12 months. The secondary objectives are to evaluate the laboratory safety of KSM-66 Ashwagandha (Withania Somnifera) on long-term administration over 12 months and to evaluate the efficacy of KSM-66 Ashwagandha (Withania Somnifera) on long-term administration over 12 months.
Interventions
- DIETARY_SUPPLEMENT KSM-66 Ashwagandha Root Extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-02-15 |
| Est. Completion | 2025-10-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06244147
The ClinicalTrials.gov registry entry for NCT06244147 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SF Research Institute, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which KSM-66 Ashwagandha Root Extract is the first listed.
NCT06244147 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06244147 about?
NCT06244147 is a clinical study titled "Long Term Safety and Efficacy of KSM-66 Ashwagandha in Adults". The primary objective is to evaluate the clinical safety of KSM-66 Ashwagandha (Withania Somnifera) on long-term administration over 12 months. The secondary objectives are to evaluate the laboratory safety of KSM-66 Ashwagandha (Withania Somnifera) on long-term administration over 12 months and to ...
What is the current status of trial NCT06244147?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2024-02-15. Estimated completion is 2025-10-15.
What interventions are being tested in trial NCT06244147?
The interventions under investigation include: KSM-66 Ashwagandha Root Extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06244147?
This trial is sponsored by SF Research Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.